Sysmex Inostics Announces Agreement With IndivuTest To Offer Sysmex Inostics Blood Based Mutation Testing In Germany, Austria And Switzerland

MUNDELEIN, Illinois and HAMBURG, Germany, April 22, 2015 /PRNewswire/ --

Sysmex Inostics, a subsidiary of Sysmex Corporation, today announced that they have signed an exclusive distributor agreement with IndivuTest GmbH, and its parent company Indivumed GmbH, a cancer research company focused on the development of individualized cancer diagnostics and therapies. This collaboration will offer Sysmex Inostics OncoBEAM™ CLIA laboratory services throughout Germany, Austria and Switzerland. IndivuTest will be responsible for commercial and sample logistics, with all testing being performed in the Sysmex Inostics’ CLIA laboratory in Baltimore, Maryland.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC